These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 34346830)
1. Primary cutaneous indolent B-cell lymphomas - a retrospective multicenter analysis and a review of literature. Olszewska-Szopa M; Sobas M; Laribi K; Bao Perez L; Drozd-Sokołowska J; Subocz E; Joks M; Zduniak K; Gajewska M; de Nalecz AK; Romejko-Jarosińska J; Kumiega B; Waszczuk-Gajda A; Wróbel T; Czyz A Acta Oncol; 2021 Oct; 60(10):1361-1368. PubMed ID: 34346830 [No Abstract] [Full Text] [Related]
2. Primary cutaneous B-cell lymphomas: part II. Therapy and future directions. Suárez AL; Querfeld C; Horwitz S; Pulitzer M; Moskowitz A; Myskowski PL J Am Acad Dermatol; 2013 Sep; 69(3):343.e1-11; quiz 355-6. PubMed ID: 23957985 [TBL] [Abstract][Full Text] [Related]
3. Primary Cutaneous B-Cell Lymphoma: Management and Patterns of Recurrence at the Multimodality Cutaneous Lymphoma Clinic of The Ohio State University. Haverkos B; Tyler K; Gru AA; Winardi FK; Frederickson J; Hastings J; Elkins C; Zhang X; Xu-Welliver M; Wong HK; Porcu P Oncologist; 2015 Oct; 20(10):1161-6. PubMed ID: 26306900 [TBL] [Abstract][Full Text] [Related]
4. Primary cutaneous marginal zone B-cell lymphoma: response to treatment and disease-free survival in a series of 137 patients. Servitje O; Muniesa C; Benavente Y; Monsálvez V; Garcia-Muret MP; Gallardo F; Domingo-Domenech E; Lucas A; Climent F; Rodriguez-Peralto JL; Ortiz-Romero PL; Sandoval J; Pujol RM; Estrach MT J Am Acad Dermatol; 2013 Sep; 69(3):357-65. PubMed ID: 23796549 [TBL] [Abstract][Full Text] [Related]
5. Radiation therapy in indolent primary cutaneous B cell lymphoma: a single institute experience. De Felice F; Grapulin L; Pieroni A; Salerno F; D'Elia GM; Pulsoni A; Musio D; Tombolini V Ann Hematol; 2018 Dec; 97(12):2411-2416. PubMed ID: 30094511 [TBL] [Abstract][Full Text] [Related]
6. Outcomes of radiation therapy of indolent cutaneous B-cell lymphomas and literature review. Gauci ML; Quero L; Ram-Wolff C; Guillerm S; M'Barek B; Lebbé C; Bagot M; Hennequin C J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1668-1673. PubMed ID: 29578630 [TBL] [Abstract][Full Text] [Related]
7. Cutaneous B-cell lymphomas: 2019 update on diagnosis, risk stratification, and management. Wilcox RA Am J Hematol; 2018 Nov; 93(11):1427-1430. PubMed ID: 30039522 [TBL] [Abstract][Full Text] [Related]
8. A Descriptive Study of 103 Primary Cutaneous B-Cell Lymphomas: Clinical and Pathological Characteristics and Treatment from the Spanish Lymphoma Oncology Group (GOTEL). Martínez-Banaclocha N; Martínez-Madueño F; Caballé B; Badia J; Blanes M; Bujanda DA; Calvo V; Gómez Codina J; Blanco CQ; Espinosa P; Lavernia J; Arroyo FRG; Risueño MG; Llorca C; Cumeras R; Pulla MP; Gumà J Cancers (Basel); 2024 Mar; 16(5):. PubMed ID: 38473391 [TBL] [Abstract][Full Text] [Related]
9. Cutaneous B-cell lymphomas: 2015 update on diagnosis, risk-stratification, and management. Wilcox RA Am J Hematol; 2015 Jan; 90(1):73-6. PubMed ID: 25535037 [TBL] [Abstract][Full Text] [Related]
10. Clinical features and treatment outcomes of primary cutaneous B-cell lymphoma: a single-center analysis in South Korea. Kim MJ; Hong ME; Maeng CH; Jung HA; Hong JY; Choi MK; Kim SJ; Ko YH; Kim WS Int J Hematol; 2015 Mar; 101(3):273-8. PubMed ID: 25552248 [TBL] [Abstract][Full Text] [Related]
11. Cutaneous B-cell lymphomas: 2013 update on diagnosis, risk-stratification, and management. Wilcox RA Am J Hematol; 2013 Jan; 88(1):73-6. PubMed ID: 23379008 [TBL] [Abstract][Full Text] [Related]
12. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia. Plosker GL; Figgitt DP Drugs; 2003; 63(8):803-43. PubMed ID: 12662126 [TBL] [Abstract][Full Text] [Related]
13. Primary cutaneous B-cell lymphomas: recent advances in diagnosis and management. Sokol L; Naghashpour M; Glass LF Cancer Control; 2012 Jul; 19(3):236-44. PubMed ID: 22710899 [TBL] [Abstract][Full Text] [Related]
14. Primary cutaneous B-cell lymphomas - clinicopathological, prognostic and therapeutic characterisation of 54 cases according to the WHO-EORTC classification and the ISCL/EORTC TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome. Golling P; Cozzio A; Dummer R; French L; Kempf W Leuk Lymphoma; 2008 Jun; 49(6):1094-103. PubMed ID: 18569636 [TBL] [Abstract][Full Text] [Related]